Skip to Main Content

Paper Details

The risk of thromboembolic events with early intravenous 2- and 4-g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial.
Transfusion
9
2022
Author NameAffiliation
Philip C SpinellaTrauma and Transfusion Medicine Research Center, University of Pittsburgh
Kimberly A ThomasTrauma and Transfusion Medicine Research Center, University of Pittsburgh
Susan M SheaTrauma and Transfusion Medicine Research Center, University of Pittsburgh
Jerrold H LevyDuke University School of Medicine
  • 1 - 4

Datasets

Release 1.2